Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,800 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review.
Jordans CCE, Vasylyev M, Rae C, Jakobsen ML, Vassilenko A, Dauby N, Grevsen AL, Jakobsen SF, Raahauge A, Champenois K, Papot E, Malin JJ, Boender TS, Behrens GMN, Gruell H, Neumann A, Spinner CD, Valbert F, Akinosoglou K, Kostaki EG, Nozza S, Giacomelli A, Lapadula G, Mazzitelli M, Torti C, Matulionyte R, Matulyte E, Van Welzen BJ, Hensley KS, Thompson M, Ankiersztejn-Bartczak M, Skrzat-Klapaczyńska A, Săndulescu O, Streinu-Cercel A, Streinu-Cercel A, Miron VD, Pokrovskaya A, Hachfeld A, Dorokhina A, Sukach M, Lord E, Sullivan AK, Rokx C; Guidelines Review Group for the projects: Optimising testing and linkage to care for HIV across Europe (OptTEST by HiE) and the Joint Action on integrating prevention, testing and linkage to care strategies across HIV, viral hepatitis, TB and STIs in Europe (INTEGRATE). Jordans CCE, et al. Among authors: thompson m. Euro Surveill. 2022 Dec;27(48):2200338. doi: 10.2807/1560-7917.ES.2022.27.48.2200338. Euro Surveill. 2022. PMID: 36695464 Free PMC article.
Long-term outcomes after tuberculosis for people with HIV in eastern Europe.
Kraef C, Bentzon A, Roen A, Bolokadze N, Thompson M, Azina I, Tetradov S, Skrahina A, Karpov I, Mitsura V, Paduto D, Trofimova T, Borodulina E, Mocroft A, Kirk O, Podlekareva DN; TB:HIV study group. Kraef C, et al. Among authors: thompson m. AIDS. 2023 Nov 1;37(13):1997-2006. doi: 10.1097/QAD.0000000000003670. Epub 2023 Jul 27. AIDS. 2023. PMID: 37503671
The Use of Beer's Restricted Medications Among US Older Patients.
Ganshert C, Thompson M, Whittle J, Davis-Maxwell A, Demchuk C, Jackson JL. Ganshert C, et al. Among authors: thompson m. J Gen Intern Med. 2024 Jun 6. doi: 10.1007/s11606-024-08848-x. Online ahead of print. J Gen Intern Med. 2024. PMID: 38844746 No abstract available.
Safety of extended pirtobrutinib exposure in relapsed and/or refractory B-cell malignancies.
Roeker LE, Coombs CC, Shah NN, Jurczak W, Woyach JA, Cheah CY, Patel K, Maddocks K, Wang Y, Zinzani PL, Munir T, Koh Y, Thompson MC, Muehlenbein CE, Wang C, Sizelove R, Abhyankar S, Hasanabba S, Tsai DE, Eyre TA, Wang M. Roeker LE, et al. Among authors: thompson mc. Acta Haematol. 2024 Jun 1. doi: 10.1159/000539587. Online ahead of print. Acta Haematol. 2024. PMID: 38824917
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer.
Fusco MJ, Casak SJ, Mushti SL, Cheng J, Christmas BJ, Thompson MD, Fu W, Wang H, Yoon M, Yang Y, Moore JN, Bi Y, Nan Y, Long CE, Auth D, Rahman NA, Tang S, Pazdur R, Fashoyin-Aje LA, Kluetz PG, Lemery SJ. Fusco MJ, et al. Among authors: thompson md. Clin Cancer Res. 2024 May 29. doi: 10.1158/1078-0432.CCR-24-0281. Online ahead of print. Clin Cancer Res. 2024. PMID: 38809262
6,800 results